Przybylski Andrzej, Małecka Longina, Pytkowski Mariusz, Chojnowska Lidia, Lewandowski Michał, Sterliński Maciej, Maciag Aleksander, Ruzyłło Witold, Szwed Hanna
2nd Coronary Department, Institute of Cardiology, Warsaw, Poland.
Kardiol Pol. 2005 Oct;63(4):391-7; discussion 398.
The implantation of a cardioverter-defibrillator (ICD) is an established method of sudden cardiac death (SCD) prevention. The value of ICD therapy in secondary prevention of SCD is unquestionable. Precise identification of high-risk patients and ICD use for primary prevention of SCD, especially in patients with hypertrophic cardiomyopathy (HCM), remain controversial. Problems include the high prevalence of complications associated with ICD implantation and optimal selection of ICDs.
To estimate the frequency and type of complications after ICD implantations in HCM patients in a long-term follow-up.
The efficacy and safety of ICD therapy were estimated in 46 HCM patients with devices implanted for a secondary (n-18) or primary prevention (n-28) of SCD.
During the mean follow-up period of 28.2+/-26.1 months (from 2 to 68) appropriate ICD interventions occurred in 10 (55%) patients of the secondary prevention group and in 3 (10%) patients of the primary prevention group. Complications were documented in 15 (33%) patients. The most frequent were inappropriate ICD interventions recorded in 14 (30%) patients. The causes of these inappropriate ICD shocks were: T-wave oversensing (7 patients), atrial fibrillation with rapid ventricular rhythm (3 patients), lead failure (2 patients), and sinus tachycardia (2 patients). In two patients infections of the ICD pocket requiring removal of the system occurred. Displacement of the lead occurred in one patient. There were no significant differences in the prevalence of complications between the primary and secondary prevention groups or in the number of inappropriate interventions with respect to ICD type.
The high rate of appropriate ICD shocks provides proof of high ICD-based SCD prevention efficacy. There is a high rate of complications observed after ICD implantation with inappropriate interventions being the most frequent among them. This indicates that careful programming of the device as well as the use of a programme with T-wave oversensing prevention should be ensured.
植入心脏复律除颤器(ICD)是预防心脏性猝死(SCD)的一种既定方法。ICD治疗在SCD二级预防中的价值是毋庸置疑的。准确识别高危患者以及将ICD用于SCD一级预防,尤其是在肥厚型心肌病(HCM)患者中,仍存在争议。问题包括与ICD植入相关的并发症高发以及ICD的最佳选择。
在长期随访中评估HCM患者植入ICD后的并发症频率和类型。
对46例植入ICD用于SCD二级预防(n = 18)或一级预防(n = 28)的HCM患者的ICD治疗效果和安全性进行评估。
在平均28.2±26.1个月(2至68个月)的随访期内,二级预防组10例(55%)患者和一级预防组3例(10%)患者发生了适当的ICD干预。15例(33%)患者记录到并发症。最常见的是14例(30%)患者出现不适当的ICD干预。这些不适当ICD电击的原因包括:T波感知过度(7例患者)、伴有快速心室率的心房颤动(3例患者)、导线故障(2例患者)和窦性心动过速(2例患者)。2例患者发生ICD囊袋感染,需要移除系统。1例患者出现导线移位。一级预防组和二级预防组之间并发症发生率或不适当干预次数在ICD类型方面无显著差异。
适当的ICD电击发生率高证明基于ICD的SCD预防效果良好。ICD植入后并发症发生率高,其中不适当干预最为常见。这表明应确保对设备进行仔细编程以及使用具有预防T波感知过度功能的程序。